These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25913101)

  • 1. To tell or not to tell: male partner engagement in a Phase 3 microbicide efficacy trial in South Africa.
    Kelly CA; Friedland BA; Morar NS; Katzen LL; Ramjee G; Mokgatle MM; Ahmed K
    Cult Health Sex; 2015; 17(8):1004-20. PubMed ID: 25913101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding".
    Montgomery ET; van der Straten A; Stadler J; Hartmann M; Magazi B; Mathebula F; Laborde N; Soto-Torres L
    AIDS Behav; 2015 May; 19(5):784-93. PubMed ID: 25416076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.
    Doggett EG; Lanham M; Wilcher R; Gafos M; Karim QA; Heise L
    J Int AIDS Soc; 2015; 18(1):20536. PubMed ID: 26700845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engaging male partners in women's microbicide use: evidence from clinical trials and implications for future research and microbicide introduction.
    Lanham M; Wilcher R; Montgomery ET; Pool R; Schuler S; Lenzi R; Friedland B
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19159. PubMed ID: 25224618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Male engagement in women's microbicide use in Kenya: Navigating gender norms.
    Schuler SR; Bukusi E
    Health Care Women Int; 2017 May; 38(5):507-519. PubMed ID: 28273003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of partnership dynamics in determining the acceptability of condoms and microbicides.
    Montgomery CM; Lees S; Stadler J; Morar NS; Ssali A; Mwanza B; Mntambo M; Phillip J; Watts C; Pool R
    AIDS Care; 2008 Jul; 20(6):733-40. PubMed ID: 18576176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention, Partners, and Power Imbalances: Women's Views on How Male Partners Affected Their Adherence to Vaginal Microbicide Gels During HIV Prevention Trials in Africa.
    Miller L; Morar N; Kapiga S; Ramjee G; Hayes R
    J Acquir Immune Defic Syndr; 2020 Dec; 85(4):458-465. PubMed ID: 33136745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'The study has taught me to be supportive of her': empowering women and involving men in microbicide research.
    Venables E; Stadler J
    Cult Health Sex; 2012; 14(2):181-94. PubMed ID: 22085043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between vaginal ring use and intimate partner violence and social harms: formative research outcomes from the CHARISMA study in Johannesburg, South Africa.
    Hartmann M; Palanee-Phillips T; O'Rourke S; Adewumi K; Tenza S; Mathebula F; Wagner D; Ayub A; Montgomery ET
    AIDS Care; 2019 Jun; 31(6):660-666. PubMed ID: 30309246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Educating men about vaginal microbicides: considerations from Kenya.
    Gitome SW; Kwena ZA; Harper CC; Cohen CR; Bukusi EA
    Cult Health Sex; 2020 Jun; 22(6):660-674. PubMed ID: 31241426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in sexual behavior during a safety and feasibility trial of a microbicide/diaphragm combination: an integrated qualitative and quantitative analysis.
    Guest G; Johnson L; Burke H; Rain-Taljaard R; Severy L; von Mollendorf C; Van Damme L
    AIDS Educ Prev; 2007 Aug; 19(4):310-20. PubMed ID: 17685844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexual pleasure, gender power and microbicide acceptability in Zimbabwe and Malawi.
    Woodsong C; Alleman P
    AIDS Educ Prev; 2008 Apr; 20(2):171-87. PubMed ID: 18433322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship Type and Use of the Vaginal Ring for HIV-1 Prevention in the MTN 020/ASPIRE Trial.
    Pleasants E; Tauya T; Reddy K; Mirembe BG; Woeber K; Palanee-Phillips T; Zimba C; Atujuna M; Montgomery ET;
    AIDS Behav; 2020 Mar; 24(3):866-880. PubMed ID: 31111297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covert use, vaginal lubrication, and sexual pleasure: a qualitative study of urban U.S. Women in a vaginal microbicide clinical trial.
    Hoffman S; Morrow KM; Mantell JE; Rosen RK; Carballo-Diéguez A; Gai F
    Arch Sex Behav; 2010 Jun; 39(3):748-60. PubMed ID: 19636696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexuality, HIV risk and potential acceptability of involving adolescent girls in microbicide research in Kisumu, Kenya.
    Montandon M; Sahin-Hodoglugil NN; Bukusi E; Agot K; Boland B; Cohen CR
    Sex Health; 2008 Dec; 5(4):339-46. PubMed ID: 19061553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges to microbicide introduction in South Africa.
    Orner P; Harries J; Cooper D; Moodley J; Hoffman M; Becker J; McGrory E; Dabash R; Bracken H
    Soc Sci Med; 2006 Aug; 63(4):968-78. PubMed ID: 16600447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives from Young South African and Zimbabwean Women on Attributes of Four (Placebo) Vaginal Microbicide Delivery Forms.
    Weinrib R; Browne EN; Shapley-Quinn MK; van der Straten A; Beksinska M; Mgodi N; Musara P; Mphili N; Schwartz JL; Ju S; Hanif H; Montgomery ET;
    AIDS Behav; 2020 Feb; 24(2):637-647. PubMed ID: 31254190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptability and performance of a nonwoven device for vaginal drug delivery among women and their male partners in KwaZulu-Natal, South Africa.
    Hart CW; Joanis C; Hartmann M; Milford C; Smit J; Beksinska M; Rambally-Greener L; Pienaar J; Mabude Z; Butterworth GAM; Sokal D; Jenkins D
    Eur J Contracept Reprod Health Care; 2019 Oct; 24(5):390-398. PubMed ID: 31517545
    [No Abstract]   [Full Text] [Related]  

  • 19. Generating CHARISMA: Development of an Intervention to Help Women Build Agency and Safety in Their Relationships While Using PrEP for HIV Prevention.
    Hartmann M; Lanham M; Palanee-Phillips T; Mathebula F; Tolley EE; Peacock D; Pascoe L; Zissette S; Roberts ST; Wagner D; Wilson E; Ayub A; Wilcher R; Montgomery ET;
    AIDS Educ Prev; 2019 Oct; 31(5):433-451. PubMed ID: 31550193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Willingness to participate in future HIV prevention trials in Beira, Mozambique.
    Meque I; Dubé K; Bierhuizen L; Zango A; Veldhuijzen N; Cumbe F; Feldblum PJ; van de Wijgert J
    Afr J AIDS Res; 2014; 13(4):393-8. PubMed ID: 25555105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.